50 Million euro investment for LUMC spin-off RougeTx advances therapies for inherited bleeding disorders.
Dr Sean Humphrey, who manages the reNEW Functional Phosphoproteomics Platform, has been awarded the Peter Doherty Investigator Award, the highest ranked recipient of a research grant in the Emerging Leadership category, by the National Health and Medical Research Council (NMHRC).
Dr Humphrey was also awarded the 2024 Commonwealth Health Minister’s Award for Excellence in Health and Medical Research for his outstanding scientific contributions.
By accepting this prestigious award, Dr Humphrey will receive a further $50,000 to help support his research in addition to his recent 5-year NHMRC Investigator Grant funding.
Dr Humphrey, from reNEW Melbourne and based at the Murdoch Children’s Research Institute, leads the Functional Phosphoproteomics group and focuses on developing new ways to study proteins and how they are modified in the cell by a process called ‘phosphorylation’.
This funding will allow Dr Humphrey and his collaborators to further explore the cells that make up medulloblastoma, the most common type of childhood brain cancer.
Read the full article on the MCRI website: https://www.mcri.edu.au/news/awards/two-accolades-for-brain-cancer-researcher
